Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

With its smallpox immunization plan now under way in the nation’s hospitals, the Centers for Disease Control and Prevention (CDC) must decide how many adverse reactions and deaths are acceptable before modifying or halting the program, told a special smallpox review panel formed at the Institute of Medicine (IOM) in Washington, DC.

IOM: Set trigger before a vaccine death occurs